 |
|
Hepatic Radiofrequency Ablation
Arch Surg. 2002;137:422-427.
Hypothesis Hepatic radiofrequency ablation (RFA) is effective in treating patients with unresectable hepatic malignancies.
Design Case series of 123 patients with unresectable hepatic tumors or tumors with histological findings not traditionally treated by means of hepatic resection were considered for hepatic RFA. Median follow-up was 20 months.
Setting Tertiary referral center.
Patients The 123 patents underwent 168 RFA sessions from January 1, 1998, through September 30, 2001. Sixty-nine patients were male and 54, female; average age was 65 years (range, 1-89 years). Fifty-two patients had metastatic colorectal cancer; 30, hepatocellular carcinoma; and 41, cancers with other histological findings.
Interventions A 200-W, cooled-tip RF probe system was used for all cases. Probe placement and ablation were monitored by means of real-time ultrasonography or fluoroscopic computed tomography. Final tissue temperature of greater than 50°C was achieved in all cases.
Results Initial treatment sessions were percutaneous in 87 patients, open operations in 33, and laparoscopic in 3. Repeated sessions were percutaneous in all but 2 patients. The mean number of lesions treated per session was 2.7 (range, 1-24). Mean tumor size was 5.2 cm (range, 0.5-15.0 cm). One death occurred within 30 days of a procedure. No hepatic bleeds, bile leaks, or adult respiratory distress syndrome occurred. Overall morbidity was 7.1%. Complications included hepatic abscesses in 4 patients, transient liver insufficiency in 3, segmental hepatic infarcts in 2, diaphragm paralysis in 1, hepatic artery–to–portal vein fistula in 1, and systemic hemolysis in 1.
Conclusions Hepatic RFA is an effective treatment option for patients with unresectable hepatic malignancies. Careful patient selection based on tumor size, location, and number and on patient clinical status should determine the choice of treatment. Further controlled trials are needed to determine the effect of hepatic RFA on long-term survival.
From the Departments of Surgery (Dr Iannitti) and Diagnostic Imaging (Drs Dupuy, Mayo-Smith, and Murphy), Brown University School of Medicine, Rhode Island Hospital, Providence.
RELATED ARTICLE
Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2002;137(4):496-497.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Percutaneous Radiofrequency Ablation of Hepatic Tumors against the Diaphragm: Frequency of Diaphragmatic Injury
Head et al.
Radiology 2007;243:877-884.
ABSTRACT
| FULL TEXT
Comparable Survival in Patients With Unresectable Hepatocellular Carcinoma Treated by Radiofrequency Ablation or Transarterial Chemoembolization
Chok et al.
Arch Surg 2006;141:1231-1236.
ABSTRACT
| FULL TEXT
RFA for Liver Tumors: Does It Really Work?
Higgins and Berger
The Oncologist 2006;11:801-808.
ABSTRACT
| FULL TEXT
Radiofrequency Ablation of Primary Lung Cancer: Results From an Ablate and Resect Pilot Study
Nguyen et al.
Chest 2005;128:3507-3511.
ABSTRACT
| FULL TEXT
Percutaneous Radiofrequency Ablation of Hepatic Tumors: Postablation Syndrome
Dodd et al.
Am. J. Roentgenol. 2005;185:51-57.
ABSTRACT
| FULL TEXT
Porcine Liver: Morphologic Characteristics and Cell Viability at Experimental Radiofrequency Ablation with Internally Cooled Electrodes
Ng et al.
Radiology 2005;235:478-486.
ABSTRACT
| FULL TEXT
Radiofrequency Ablation of Thoracic Lesions: Part 1, Experiments in the Normal Porcine Thorax
Morrison et al.
Am. J. Roentgenol. 2005;184:375-380.
ABSTRACT
| FULL TEXT
Minimizing Diaphragmatic Injury During Radiofrequency Ablation: Efficacy of Intraabdominal Carbon Dioxide Insufflation
Raman et al.
Am. J. Roentgenol. 2004;183:197-200.
ABSTRACT
| FULL TEXT
Radiofrequency Ablation for Subcapsular Hepatocellular Carcinoma
Poon et al.
Ann. Surg. Oncol. 2004;11:281-289.
ABSTRACT
| FULL TEXT
Effectiveness of Radiofrequency Ablation for Hepatocellular Carcinomas Larger Than 3 cm in Diameter
Poon et al.
Arch Surg 2004;139:281-287.
ABSTRACT
| FULL TEXT
Percutaneous Imaging-Guided Radiofrequency Ablation in Patients With Colorectal Pulmonary Metastases: 1-Year Follow-Up
Steinke et al.
Ann. Surg. Oncol. 2004;11:207-212.
ABSTRACT
| FULL TEXT
Invited Commentary
Razavi
RadioGraphics 2003;23:134-136.
FULL TEXT
|
